Related Experiment Video
Updated: Mar 29, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of
Mi-Hee Jun1, Jeong-Ho Han2, Yu-Kyung Lee3
1Department of Biotechnology and Biological Sciences, Hannam University, 1646 Yuseongdaero, Yu-seong-gu, Daejeon, 305-811, South Korea. mhjun8872@gmail.com.
Background:
Transmembrane protein 106B (TMEM106B) has been identified as a risk factor for frontotemporal lobar degeneration, which is the second most common form of progressive dementia in people under 65 years of age. Mutations in charged multivesicular body protein 2B (CHMP2B), which is involved in endosomal protein trafficking, have been found in chromosome 3-linked frontotemporal dementia. Despite the number of studies on both CHMP2B and TMEM106B in the endolysosomal pathway, little is known about the relationship between CHMP2B and TMEM106B in the endosomal/autophagy pathway.
Results:
This study found that endogenous TMEM106B was partially sequestered in CHMP2B-positive structures, suggesting its possible involvement in endosomal sorting complexes required for transport (ESCRT)-associated pathways. The role of single nucleotide polymorphisms of TMEM106B (T185, S185, or S134N) in the ESCRT-associated pathways were characterized. The T185 and S185 variants were more localized to Rab5-/Rab7-positive endosomes compared with S134N, while all of the variants were more localized to Rab7-positive endosomes compared to Rab5-positive endosomes. T185 was more associated with CHMP2B compared to S185. Autophagic flux was slightly reduced in the T185-expressing cells compared to the control or S185-expressing cells. Moreover, T185 slightly enhanced the accumulation of EGFR, impairments in autophagic flux, and neurotoxicity that were caused by CHMP2B(Intron5) compared to S185-expressing cells.
Conclusions:
These findings suggest that the T185 variant functions as a risk factor in neurodegeneration with endolysosomal defects. This study provides a better understanding of pathogenic functions of TMEM106B, which is a risk factor for the progression of neurodegenerative diseases that are associated with endosomal defects in the aged brain.
Insights
Transmembrane protein 106B (TMEM106B) variants influence endosomal trafficking and autophagy, impacting neurodegeneration risk. The T185 variant exacerbates CHMP2B-associated neurotoxicity, highlighting its role in endolysosomal defects.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Transmembrane protein 106B (TMEM106B) is a risk factor for frontotemporal lobar degeneration, a common dementia.
- Mutations in charged multivesicular body protein 2B (CHMP2B) are linked to frontotemporal dementia.
- The relationship between TMEM106B and CHMP2B in endosomal/autophagy pathways is poorly understood.
Purpose of the Study:
- To investigate the relationship between TMEM106B and CHMP2B in the endosomal/autophagy pathway.
- To characterize the role of TMEM106B single nucleotide polymorphisms (SNPs) in endosomal sorting complexes required for transport (ESCRT)-associated pathways.
Main Methods:
- Immunofluorescence microscopy to assess co-localization of TMEM106B variants with endosomal markers (Rab5, Rab7) and CHMP2B.
- Analysis of autophagic flux in cells expressing different TMEM106B variants.
- Assessment of EGFR accumulation and neurotoxicity in cells expressing TMEM106B variants and CHMP2B(Intron5).
Main Results:
- Endogenous TMEM106B partially co-localized with CHMP2B-positive structures.
- TMEM106B variants T185 and S185 localized more to Rab7-positive endosomes than S134N.
- The T185 variant showed greater association with CHMP2B, reduced autophagic flux, and enhanced CHMP2B(Intron5)-induced EGFR accumulation, autophagic impairment, and neurotoxicity compared to S185.
Conclusions:
- The T185 variant of TMEM106B functions as a risk factor in neurodegeneration associated with endolysosomal defects.
- These findings enhance understanding of TMEM106B's pathogenic roles in age-related neurodegenerative diseases with endosomal dysfunction.
More Related Videos
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
08:27Expression and Purification of the Human Lipid-sensitive Cation Channel TRPC3 for Structural Determination by Single-particle Cryo-electron Microscopy
Published on: January 7, 2019
Related Concept Videos
Tail-anchoring of Proteins in the ER Membrane
Master Transcription Regulators
Microtubule Associated Proteins (MAPs)
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...